The changes in the catalytic properties and in the stability of the PGK1 variants, mainly due to the local changes evidenced by the X-ray structures, suggest also changes in the functional role of PGK to support the biosynthetic need of the growing and proliferating tumour cells.Ĭitation: Fiorillo A, Petrosino M, Ilari A, Pasquo A, Cipollone A, Maggi M, et al. Our results clearly show that the variants display a decreased catalytic efficiency and/or thermodynamic stability and an altered local tertiary structure, as shown by the solved X-ray structures. In this study we analyzed the effect of the single nucleotide variants found in cancer tissues on the PGK1 structure and function.
Moreover, several somatic variants of PGK1 have been identified in tumors. Recently, phosphoglycerate kinase 1 (PGK1), an ubiquitous enzyme expressed in all somatic cells that catalyzes the seventh step of glycolysis which consists of the reversible phosphotransfer reaction from 1,3-bisphosphoglycerate to ADP, has been discovered to be overexpressed in many cancer types. In the last years, glycolytic enzymes have been identified as potential targets for alternative anticancer therapies. Under hypoxic conditions they shift from oxidative phosphorylation to aerobic glycolysis, a behavior known as Warburg effect. Cancer cells are able to survive in difficult conditions, reprogramming their metabolism according to their requirements.
0 kommentar(er)
